UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Commission File Number: 001-41937
Psyence Biomedical Ltd.
(Translation of registrant’s name into English)
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
☒
Form 20-F ☐
Form 40-F
Explanatory Note
Psyence Biomedical Ltd. (the “Company”) is filing this
Form 6-K to file its unaudited interim consolidated financial statements for the three and six months ended September 30, 2025 and 2024
(the “Interim Financial Statements”), along with its corresponding Management’s Discussion and Analysis.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Unaudited Condensed Consolidated Financial Statements for the Three and Six Months Ended September 30, 2025 and 2024. |
| 99.2 |
|
Management Discussion and Analysis for the Unaudited Condensed Consolidated Financial Statements for the Three and Six Months Ended September 30, 2025 and 2024. |
| 101.INS |
|
Inline XBRL Instance Document. |
| 101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Dated: November 20, 2025
| Psyence Biomedical Ltd. |
|
| |
|
|
| By: |
/s/ Jody Aufrichtig |
|
| Name: |
Jody Aufrichtig |
|
| Title: |
Chief Executive Officer and Director |
|
3
